-
T-Cell Exhaustion in EBV DNAemic Solid Organ Transplant Recipients
-
T-Cell Responses in Solid Organ Transplant Recipients with SARS-CoV-2 Infection
-
T-cell-Mediated Immunity to Sars-cov-2 Defines Covid-19 Risk and Severity in Transplanted and Non-Transplanted Individuals and Associates with Myeloid-Derived Suppressor Cells
-
Tacrolimus Dose Requirements in Lung Transplant Recipients on Systemic Azole Antifungals: The Influence of Race and Transplant Indication
-
Tacrolimus Shortage and the Rush to Convert: An Unexpected Burden on the System During the Covid-19 Pandemic?
-
Tacrolimus Therapeutic Exposure is Not Consistently Predicted by Target Troughs or CYP3A5 Variants in Stable Renal Transplant Recipients
-
Tacrolimus Variability Score Outperforms Coefficient of Variation in Predicting Clinical Outcomes of Living Kidney Transplantation
-
Targeting Calcineurin/nfatc2 Signaling to Restore Pancreatic Beta-cell Function in Islet Transplantation
-
Targeting Il-21 Receptor Shifts Tfh/tfr Balance and Ameliorateschronic Antibody Mediated Rejection
-
Taurodeoxycholic Acid and L-valine Ameliorate Macrophage Driven Alloimmunity in Obese Transplant Recipients
- « Previous Page
- 1
- …
- 117
- 118
- 119
- 120
- 121
- …
- 139
- Next Page »